Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2026 Earnings Call Transcript May 13, 2026
Takeda Pharmaceutical Company Limited beats earnings expectations. Reported EPS is $-0.04928, expectations were $-0.07543.
Christopher David O’Reilly: [Audio Gap] [Operator Instructions] [Interpreted] Before starting, I’d like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ...
